about
Angiotensin AT1/AT2 receptors: regulation, signalling and function.Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin systemThe evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.The past, present and future of angiotensin II type 2 receptor stimulation.Inhibition of PCSK9: a novel approach for the treatment of dyslipidemia.AT2 receptors targeting cardiac protection post-myocardial infarction.Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.AT2 receptors in cardiovascular and renal diseases.Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells.Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells.Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis.Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components.Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis.Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter.Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain.Small animal Look-Locker inversion recovery (SALLI) for simultaneous generation of cardiac T1 maps and cine and inversion recovery-prepared images at high heart rates: initial experience.AT1-receptor blockade attenuates outward aortic remodeling associated with diet-induced obesity in mice.Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease.Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury.Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance.ATR (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat
P50
Q35150079-334767B7-EAEA-445F-9D02-B80987C8B391Q35178549-04FBD1CD-B24E-40E5-9379-818A19DDD791Q36296024-127FE498-C416-483D-88CA-8EA535F7A749Q37611981-39D46B9B-A698-4C9A-89A6-9E559D6CD164Q37622572-4128CCA5-F302-4023-9069-6A1CFA33BB3BQ38199274-199BCA2A-A386-4554-B726-40DF212CD6C7Q38208962-15A90F60-7331-4E8F-8B77-58351EB2EA6BQ38628641-A1C5270E-1A95-458A-AEA7-B32836ACCC93Q39282244-98F768A5-6DDC-4CF4-A303-770893F5257FQ39426680-97550A56-D011-43F7-98A5-54E2E49BAD9DQ39864835-D796CB17-5F3E-4FD9-80EC-B0EB7F1D89C6Q42458466-6BF6161E-59E9-4E62-B0CD-E924C73FA394Q42683758-45AE2B8B-D768-4A0D-991F-5B604A971E51Q43435731-2D6D2E7B-3371-405D-A7BE-90CF583C6B3AQ43518551-C1C711A8-7A0A-44F4-B9A9-A6895697A50AQ44260089-E8E5FBAD-9312-4E38-A54E-63ED4E99B2E6Q44454656-D7BE94B1-419C-4122-819A-A0B157B6F6EDQ46247127-C2CF6C94-304B-4EEA-98F0-20E062641A24Q46477370-FA18B5CC-8960-4D4E-8E99-E825F3D2CA8AQ46956459-B54251E6-4D40-4867-A5CA-FCD715627F4FQ50926536-9406E90F-70E8-4AF1-8DCE-8F85C5859226Q51048934-F1FF6ACD-06C8-42A4-BF50-0DEB4FAE99B8Q52890458-4D8890EE-A247-448C-A8FE-E1528D56250FQ52892982-A6C387A7-C63C-4566-9EE1-CBE8B4BDFB00Q52901073-53A796A3-A747-4199-895F-00929F2808B7Q54506199-AE9ECE05-7692-4341-927F-9786FD483E5AQ54733634-B92CA3FF-A8B6-486F-8C67-D892AB013226Q56961189-D13EF30A-71AE-43CA-8826-0BB97E168873
P50
name
Elena Kaschina
@ast
Elena Kaschina
@en
Elena Kaschina
@nl
type
label
Elena Kaschina
@ast
Elena Kaschina
@en
Elena Kaschina
@nl
prefLabel
Elena Kaschina
@ast
Elena Kaschina
@en
Elena Kaschina
@nl